In addition, EphA2 was considered to be an epithelial cell receptor for Epstein–Barr virus (EBV) entry21,22, and EBV-infection has been shown to promote VM in nasopharyngeal carcinoma (NPC) and EBV-associated gastric cancer (EBVaGC)24. Here, EPHA2 is linked to gastric cancer.